This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Examining Current Perspectives in Psoriasis Management: Patient and Provider Insights to Optimize Care

Examining Current Perspectives in Psoriasis Management: Patient and Provider Insights to Optimize Care

Format

Patient Case Study

Time to Complete

1 hour

Released

January 31, 2017

Expires

January 31, 2018
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 Credit(s)TM
1.00 / ANCC Contact Hours
1.00 / AAPA Category 1 CME Credit
1.00 / AANP Contact Hours (0.25 pharmacology hours)

Accredited Provider

In support of improving patient care, Creative Educational Concepts is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Commercial Supporter

This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com.

Program Description

Uncontrolled psoriatic disease significantly impacts the quality of life of those affected, resulting in depression, anxiety, and social distress due to the physical burden of the disease. As the understanding and treatment of psoriasis has changed significantly in recent years, it is critical that clinicians who manage this disease have a thorough understanding of the disease and treatment options available. The goal of this educational activity is to provide dermatology physicians, physician assistants (PAs), nurses, nurse practitioners (NPs), and other members of the psoriasis care team with an understanding of the patient’s perspective of disease severity and treatment success to enable clinicians to better design treatment plans to improve both clinical outcomes and patient quality of life. To help clinicians truly understand the patient’s perspective of psoriatic disease, patient representatives from the National Psoriasis Foundation will share their personal stories and insights regarding the day-to-day struggles of living with psoriasis.

Agenda

Pre-test
Part I: Beneath the Skin: Personal Patient Stories on Living with Psoriasis
Part II: Clearing Up Communication: Improving Patient and Provider Dialogue to Reach Treatment Goals
Part III: Personalizing Psoriasis Therapy: Examining Pharmacologic Treatment Options
Post-test and Evaluation

Intended Audience

Dermatologists, nurse practitioners, nurses, physician assistants, and other healthcare professionals who treat patients with psoriasis.

Educational Objectives

Upon completion of this activity, participants will be able to:

  • Assess quality of life in patients with psoriasis including factors such as social burden, intimacy, relationships, employment, workplace productivity, and comorbid psychiatric conditions.
  • Discuss disease severity and treatment satisfaction with patients who have psoriasis in order to eliminate discrepancies between clinician views of psoriatic disease, goals of treatment, and the opinions of the patient.
  • Design individualized treatment plans for patients with psoriasis using clinical safety and efficacy data that take into account quality of life and the patient’s perspectives on disease severity and measures of treatment success.

Conflict Of Interest Disclosure Policy

In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.

Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in educational presentations.

Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.

Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Faculty

Neil J. Korman, MD, PhD
Professor of Dermatology
Clinical Director
Murdough Family Center for Psoriasis
University Hospitals
Cleveland Medical Center
Cleveland, OH

Dr. Korman has disclosed that he is a consultant for Novartis and Pfizer; receives grant/research funding from Abbvie, Amgen, Celgene, Chugai, Lilly, Janssen, Kyowa, Merck, Pfizer, Regeneron, and Trevi; and is a member of the speakers’ bureaus for Abbvie, Celgene, Lilly, Janssen, Novartis, Pfizer, and Regeneron.

B. Jang Mi Johnson, PA-C
Lakeview Dermatology
Chicago, IL

Ms. Johnson has disclosed that she is a consultant for Taro Pharmaceuticals; and is a member of the speakers’ bureaus for Galderma and Aqua Pharmaceuticals.

Melodie Young, RN, ANP-C
Modern Dermatology
Dallas, TX

Ms. Young has disclosed that she is a consultant for Abbvie, Celgene, Lilly, and Novartis; and receives grant/research at her facility from Boehringer Ingelheim, Celgene, Dermira, GlaxoSmithKline, Janssen, Lilly, Novartis, Pfizer, Regeneron, UCB, and Valeant.

Planners and Reviewers Disclosures

Planner
Adrienne Matson, PharmD, BCPS, has no financial relationships to disclose in relation to the content of this activity.

Peer Reviewers
David Pariser, MD, has disclosed that he receives grant/research funding from LEO Pharma Inc., Abbott Laboratories, Amgen, Bickel Biotechnology, Celgene, Lilly, Novartis, Novo Nordisk, Ortho Dermatologies, Photocure ASA, Promius Pharmaceuticals, Regeneron, Stiefel a GSK company, and Valeant Pharmaceuticals International. He receives honoraria from Bickel Biotechnology, Biofrontera AG, Celgene, Dermira, DUSA Pharmaceuticals, LEO Pharma US, Novartis, Pfizer, Promius Pharmaceuticals, Regeneron, TheraVida, and Valeant Pharmaceuticals International.

Kristine Kucera, PA-C, MPAS, DHS, has no financial relationships to disclose in relation to the content of this activity.

Todd Martin, ARNP, has no financial relationships to disclose in relation to the content of this activity.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

In support of improving patient care, Creative Educational Concepts is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement

CEC designates this online educational activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurses

Accreditation Statement

In support of improving patient care, Creative Educational Concepts is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Designation Statement

This activity is designated for 1.00 contact hour.

Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

Credit

1.00

Type

AAPA Category I CME credit

Accreditation Statement

This program was planned in accordance with the AAPA's CME Standards for Enduring Material Programs and for Commercial Support of Enduring Material Programs.

Designation Statement

This program has been reviewed and is approved for a maximum of 1.00 AAPA Category 1 CME credits by the PA Review Panel. Approval is valid for one year from the issue date of 1/30/2017. Participants may submit the post-test at any time during that period.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement

This activity is approved for 1.0 contact hour(s) of continuing education (which includes 0.25 hours of pharmacology) by the American Association of Nurse Practitioners.

Designation Statement

Activity ID 16122455. This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.

Disclaimer

It is the policy of CEC to ensure independence, balance, objectivity, scientific rigor, and integrity in their continuing education activities.

Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer's package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.

Fair balance is achieved through ongoing and thorough review of all presentation materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by CEC for any product or manufacturer identified.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

If you have any questions relating to the accreditation of this activity, please contact Creative Educational Concepts at (866) 360-1717.

If you have any other questions relating to your certificate or other issues with this activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue